Abnormal uterine bleeding is a common cause for visits to gynecology polyclinics and one of the treatment options is levonorgestrelcontaining intrauterine device (LNG IUD; Mirena®). The aim of thisstudy is to evaluate patient satisfaction following insertion of Mirena® in women with the indication of abnormal uterine bleeding andto share our data concerning the use of Mirena. The study populationof this retrospective study consisted of women with the diagnosisof dysfuntional abnormal uterine bleeding with Mirena® insertedbetween 1 January 2015-31 December 2015. Information about age,obstetric and gynecologic history of the patients, histologic diagnosisof endometrial sampling, pelvic ultrasound reports were retrievedfrom medical records of the patients. Afterwards, interviews on phone were conducted. Patient satisfaction, complications, rate of amenorrhea, rate of expulsion or displacement, need for removal and ifremoved the treatment modality preferred were noted. Patient satisfaction was assessed by a scale of four as not satisfied, satisfied, verysatisfied and extremely satisfied. A total of 61 Mirena® were insertedduring study period and 50 patients were included in the study. Wecould interview with 31 patients on phone. No complication occurredrelated to vaginal insertion of Mirena® Twelve patients were amenorrheic, 4 patients oligomenorrheic, 4 patients were complaining ofmetrorrhagia (spotting). Displacement of Mirena® did not occur, however in 6.45%. of the patients Mirena® came out accidentally. Fourpatients wanted their Mirena® to be removed. Eight patients were“not satisfied” at all, the other patients were satisfied from the treatment. As a result, Mirena® was overall a well-tolerated treatmentmodality and around three-quarter of the patients with Mirena® inserted for the treatment of abnormal uterine bleeding are satisfiedfrom the treatment.